semaglutide nytimes What Is Ozempic and Why Is It Getting So Much Attention? Doctors urge caution on diabetes

This means the FDA is now (finally!) coming after the entire compounded GLP-1 market, including the injectable business that HIMS and others have been operating profitably for over a year since the semaglutide shortage was officially resolved in early 2025, largely without meaningful enforcement

GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction US: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease

Clinical trials show that semaglutide users lose approximately 1522% of body weight over 68 weeks when combined with diet and exercise

Khng phn bit c mu sc

Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: a randomized controlled trial (CODEX)

Available statewide in Colorado Wherever you live in Colorado, telehealth gives you the same access to GLP-1 shots as the largest US cities